Glucotrol Xl
indicated to manage blood sugar levels in type 2 diabetes mellitus and intended to support patients in maintaining glycaemic control.
Strengths: 5 · 10mg
Where to Check Availability
Medicine details
- Conditions
- Alternative names
Minodiab
- Therapeutic class
Sulfonylurea
- Pharmacological class
Sulfonylurea
- Precautions and warnings
risk of hypoglycaemia; avoid skipping meals; caution in elderly patients
- Minor side effects
dizziness; headache; nausea
- Moderate side effects
skin rash; weight gain
- Dosage forms
Prolonged-release tablet
- Administration route
Oral use
- Prescription status
POM
- Manufacturer
Pfizer
- Onset Time
1–3 hours
- Duration
12–24 hours
- Storage instructions
Store at controlled room temperature.
- Drug interactions
alcohol; beta-blockers; anticoagulants
- Age restrictions
Not recommended for children.
- Pregnancy and breastfeeding
Pregnancy: not recommended. Breastfeeding: not recommended.
Contraindications
type 1 diabetes; diabetic ketoacidosis; severe hepatic impairment; hypersensitivity to sulfonylureas
Serious side effects
severe hypoglycaemia — requires immediate medical attention; jaundice — requires immediate medical attention
Patient summary
indicated to manage blood sugar levels in type 2 diabetes mellitus and intended to support patients in maintaining glycaemic control.
Mechanism of action
Glipizide is a second-generation sulfonylurea. It lowers blood sugar by stimulating the release of insulin from the beta cells of the pancreas.
Glucotrol Xl
indicated to manage blood sugar levels in type 2 diabetes mellitus and intended to support patients in maintaining glycaemic control.
Editorial Notes
- Active ingredient(s): Glipizide
- Listed indication(s): Type 2 Diabetes Mellitus
Usually available as
- 360 tablets - 5 mg692-5-mg-3098
- 240 tablets - 10 mg692-10-mg-3104